News Release

Printer Friendly Version View printer-friendly version
<< Back
Aralez to Participate at Two Upcoming Healthcare Conferences

MISSISSAUGA, Ontario, Nov. 30, 2016 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced that Adrian Adams, Chief Executive Officer, will participate in the following healthcare conferences:

  • Guggenheim's One-on-One Healthcare Conference in Boston on Tuesday, December 13, 2016
  • BMO Healthcare Conference in New York on Wednesday, December 14, 2016 at 11:00 a.m.

A live webcast and audio archive for the BMO event may be accessed from the Investors section of the Aralez website at Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

About Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular, pain and other specialty areas. Aralez's Global Headquarters is in Ontario, Canada, the US Headquarters is planned to be in Princeton, NJ and the Ireland Headquarters is in Dublin, Ireland. More information about Aralez can be found at

Contact Information:
Aralez Pharmaceuticals US Inc.
Nichol Ochsner
Executive Director,
Investor Relations & Corporate Communications

Logo -

To view the original version on PR Newswire, visit:

SOURCE Aralez Pharmaceuticals Inc.

Data provided by Nasdaq. Minimum 15 minutes delayed.